Is the weak yuan aimed at the Fed?

Michael McKenna

Head of Editorial Content, Saxo Bank Group

The Chinese yuan continues its precipitous decline against the greenback with USDCNY climbing past 6.70. While some analysts are asking whether this represents a trade war-linked 'weaponisation' of the renminbi, Saxo Bank Head of FX Strategy John Hardy says that the more interesting question is whether the move is fact aimed at Federal reserve chief Jerome Powell.

"If we look back to early 2016, we can find a key instance of the Fed backing away from its forward guidance on a pronounced upward move in the dollar," says Hardy.

Chinese shares, meanwhile, continue to fall with the CSI 300 index declining by 1% overnight; the index is now down 25% for the year.

"We are now seeing sell-side analysts questioning whether this represents a buying opportunity," says Saxo Head of Equity Strategy Peter Garnry, "but we think that investors looking to go long could still be in a 'catch the falling knife'-type scenario... we would look to the CNY's finding a floor before broadly turning to Chinese shares."

Despite the note of caution, however, Garnry notes that several Chinese stocks are rising within Saxo's Equity radar model with five shares now in the top 20, including names like Kweichow Moutai and ANTA Sports.

Looking at equities in the US, Saxo Bank technical analyst Kim Cramer Larsson says that the Nasdaq 100 looks primed to recapture last week's gap while the S&P 500 is trading above a very key support level at 2,700 with sentiment tilted bearish.

In Europe, Larsson sees the Dax index primed for a potential bounce from support towards the 12,500-600 area.

Finally, John Hardy notes the euro's limited bounce after Germany's CSU and CDU parties reached a migration deal; in USD, he points to a near-record 60.2 showing from the ISM manufacturing reading as another sign that the US economy continues to perform robustly.

CSI 300 (source: Bloomberg)

Access both platforms from your single Saxo account.

Disclaimer

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice or a personal recommendation and does not take into consideration your objectives, financial situation and needs. Saxo Capital Markets UK Limited will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information. We assume no liability for errors, inaccuracies or omissions contained within these materials.

It is important that you understand that with investments, your capital is at risk. We offer leveraged products which carry risk and can result in losses that exceed deposits. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more here.

Additional Key Information Documents are available in our trading platform.

Saxo Capital Markets UK is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871

Please read our full disclaimer - https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer